Novo Nordisk, Health2Sync partner to bring diabetes app to Japan by Conor Hale Monday, March 11, 2019 Novo Nordisk has partnered with Taiwan-based Health2Sync to help promote the latter’s digital diabetes management app in Japan.
Akili, Shionogi pair up on digital therapies for Japan & Taiwan by Conor Hale Thursday, March 7, 2019 Akili Interactive is teaming up with Osaka-based Shionogi to help bring the first prescription digital therapeutics to Japan and Taiwan.
Daiichi makes exec changes across its U.S. research unit by Ben Adams Friday, February 22, 2019 Japanese pharma Daiichi Sankyo is looking to boost its research focus with a series of changes across its R&D.
New discoveries in cancer and antibiotics resistance—News of Note by Arlene Weintraub Monday, February 11, 2019 The week’s biotech news included insight into how circulating tumor cells form metastases and how bacteria evade copper antibiotics.
Amgen gets first OK for Evenity in Japan as FDA panel looms by Phil Taylor Wednesday, January 9, 2019 Amgen heads into an FDA adcomm for new osteoporosis drug Evenity next week comforted by a first approval for the bone-building drug in Japan.
Chugai preps filings for Soliris rival in rare disease by Phil Taylor Wednesday, December 19, 2018 Chugai has the phase 3 data it needs to file IL-6-targeting antibody satralizumab for approval in neuromyelitis optica spectrum disorder next year.
Taiho swells its U.S.-based VC fund to $300M by Phil Taylor Tuesday, October 16, 2018 Seeking further returns from Taiho Ventures, Taiho Pharma just decided to multiply its investment pool sixfold to $300 million.
Modulus Discovery rakes in $7.2M series A to fund R&D by Joseph Keenan Monday, August 13, 2018 Japan-based Modulus Discovery raised $7.2 million in series A funds that will be used to bolster its R&D platform efforts.
